Ads
related to: afp marker for liver cancer treatment- Possible Side Effects
Visit Site To See Possible Side
Effects & Safety Information.
- Dosing Schedule
Read About Dosing Schedules, Dosing
Modifications & Safety Information.
- Financial Assistance
Find Financial Support Options
For Your Patients On HCP Website.
- Clinical Trial Data
Read About Efficacy & Safety For An
HCC Treatment On Official HCP Site.
- Contact A Representative
Visit HCP Website To Contact A Rep
About HCC Treatment Information.
- Manage Adverse Reactions
Learn How To Manage Select Adverse
Reactions & Safety On HCP Site.
- Possible Side Effects
Search results
Results From The WOW.Com Content Network
The usual markers for liver disease – aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase – are often normal or only slightly elevated. FLC often does not produce alpha fetoprotein (AFP), a widely used marker for conventional hepatocellular carcinoma.
The AFP-L3% assay, a liquid-phase binding assay, will help to identify at-risk subjects earlier, allowing for more intense evaluation for evidence of HCC according to existing practice guidelines in oncology. AFP-L3% is the standard for quantifying the L3 isoform of AFP in serum of high risk chronic liver disease (CLD) patients.
Serum levels are useful in assessing response to treatment. [citation needed] Like any elevated tumor marker, elevated AFP by itself is not diagnostic, only suggestive. Tumor markers are used primarily to monitor the result of a treatment (e.g. chemotherapy). If levels of AFP go down after treatment, the tumor is not growing.
Very high AFP levels may be subject to hooking (see Tumor marker), which results in the level being reported significantly lower than the actual concentration. [29] This is important for analysis of a series of AFP tumor marker tests, e.g. in the context of post-treatment early surveillance of cancer survivors, where the rate of decrease of AFP ...
Alpha-fetoprotein (AFP) is significantly expressed in foetal liver. However, the mechanism that led to the suppression of AFP synthesis in adults is not fully known. Exposure of the liver to cancer-causing agents and arrest of liver maturation in childhood can lead to the rise in AFP. AFP can reach until 400–500 μg/L in hepatocellular ...
Consultant interventional radiologist Dr Brian Stedman said his team had performed 300 procedures in 100 patients whose form of eye cancer known as ocular melanoma had spread to the liver, called ...
Ads
related to: afp marker for liver cancer treatment